Influence of immunomodulatory drugs on the gut microbiota

被引:19
|
作者
Cohen, Inessa [1 ]
Ruff, William E. [1 ]
Longbrake, Erin E. [1 ]
机构
[1] Yale Univ, Dept Neurol, POB 208018, New Haven, CT 06520 USA
关键词
REGULATORY T-CELLS; CHAIN FATTY-ACIDS; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR; GLATIRAMER ACETATE; GASTROINTESTINAL TOXICITY; MYCOPHENOLATE-MOFETIL; INTESTINAL MICROBIOTA; PREVOTELLA-HISTICOLA; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.trsl.2021.01.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Immunomodulatory medications are a mainstay of treatment for autoimmune diseases and malignancies. In addition to their direct effects on immune cells, these medications also impact the gut microbiota. Drug-induced shifts in commensal microbes can lead to indirect but important changes in the immune response. We performed a comprehensive literature search focusing on immunotherapy/microbe interactions. Immunotherapies were categorized into 5 subtypes based on their mechanisms of action: cell trafficking inhibitors, immune checkpoint inhibitors, immunomodulators, antiproliferative drugs, and inflammatory cytokine inhibitors. Although no consistent relationships were observed between types of immunotherapy and microbiota, most immunotherapies were associated with shifts in specific colonizing bacterial taxa. The relationships between colonizing microbes and drug efficacy were not well-studied for autoimmune diseases. In contrast, the efficacy of immune checkpoint inhibitors for cancer was tied to the baseline composition of the gut microbiota. There was a paucity of high-quality data; existing data were generated using heterogeneous sampling and analytic techniques, and most studies involved small numbers of participants. Further work is needed to elucidate the extent and clinical significance of immunotherapy effects on the human microbiome (Translational Research 2021; 233:144-161) Abbreviations: CD = cluster of differentiation; Th = helper T cells; Treg = regulatory T-cell subsets; GALT = gut-associated lymphoid tissue; TLR2 = Toll-like receptor-2; MMF = Mycophenolate mofetil; MTX = Methotrexate; RA = Rheumatoid Arthritis; MS = Multiple Sclerosis; MLGs = microbial linkage groups; ALZ = Alemtuzumab; CTLA-4 = cytotoxic T-lymphocyte-associated protein 4; PD-1 = programmed cell death protein 1; PD-L1 = programmed cell death protein 1 ligand 1; PD-L2 = programmed cell death protein 1 ligand 2; ICIs = Immune checkpoint inhibitors; NTZ = Natalizumab; LPS = lipopolysaccharide; DMF = Dimethyl fumarate; GA = Glatiramer acetate; IFNb = Interferon beta; TNFi's = TNF inhibitors; TNFa = tumor necrosis factor alpha; IgA = immu
引用
收藏
页码:144 / 161
页数:18
相关论文
共 50 条
  • [1] The influence of the gut microbiota on the bioavailability of oral drugs
    Xintong Zhang
    Ying Han
    Wei Huang
    Mingji Jin
    Zhonggao Gao
    ActaPharmaceuticaSinicaB, 2021, 11 (07) : 1789 - 1812
  • [2] The influence of the gut microbiota on the bioavailability of oral drugs
    Zhang, Xintong
    Han, Ying
    Huang, Wei
    Jin, Mingji
    Gao, Zhonggao
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (07) : 1789 - 1812
  • [3] Mining the Human Gut Microbiota for Immunomodulatory Organisms
    Geva-Zatorsky, Naama
    Sefik, Esen
    Kua, Lindsay
    Pasman, Lesley
    Tan, Tze Guan
    Ortiz-Lopez, Adriana
    Yanortsang, Tsering Bakto
    Yang, Liang
    Jupp, Ray
    Mathis, Diane
    Benoist, Christophe
    Kasper, Dennis L.
    CELL, 2017, 168 (05) : 928 - +
  • [4] The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
    Chi, Mingxuan
    Ma, Kuai
    Wang, Jing
    Ding, Zhaolun
    Li, Yunlong
    Zhu, Shaomi
    Liang, Xin
    Zhang, Qinxiu
    Song, Linjiang
    Liu, Chi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [5] Gut microbiota-host immunomodulatory interactions
    Geva-Zatorsky, Naama
    Alvarez, David
    Hudak, Jason E.
    Mans, Nicola C. Reading
    Erturk-Hasdemir, Deniz
    Dasgupta, Suryasarathi
    von Andrian, Ulrich
    Kasper, Dennis
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [6] Immunomodulatory effect of Liangyi paste on the gut microbiota of mice
    Luo, Jing
    Wu, Yong-Xi
    Ma, Li-Ting
    Zhang, Mei-Yu
    Li, Fang-Tong
    Cai, Yong-Yu
    Zheng, Fei
    Yue, Hao
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 236
  • [7] The Immunomodulatory Effect of β-Glucan Depends on the Composition of the Gut Microbiota
    Sung, Miseon
    Yoon, Yohan
    Lee, Jeeyeon
    FOODS, 2023, 12 (17)
  • [8] Interaction of drugs with gut microbiota modulators
    Kim, Dong-Hyun
    DRUG METABOLISM REVIEWS, 2023, 55 (03) : 181 - 194
  • [9] The metabolic effect of gut microbiota on drugs
    Xie, Yuan
    Hu, Fangdi
    Xiang, Dawei
    Lu, Hui
    Li, Wenbin
    Zhao, Anpeng
    Huang, Longji
    Wang, Rong
    DRUG METABOLISM REVIEWS, 2020, 52 (01) : 139 - 156
  • [10] Hormonal drugs: Influence on growth, biofilm formation, and adherence of selected gut microbiota
    Hammouda, Zainab K.
    Wasfi, Reham
    Abdeltawab, Nourtan F.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13